|
TOP
|
|
TOPIRAMATEtablet
|
HIGHLIGHTS OF PRESCRIBING INFORMATION |
These highlights do not include all the information needed to use topiramate tablets safely and effectively. See full prescribing information for topiramate tablets.
TOPIRAMATE tablets for oral use
Initial U.S. Approval: 1996
|
|
INDICATIONS AND USAGE
|
|
Topiramate tablets are an antiepileptic (AED) agent indicated for:
-
Monotherapy epilepsy: Initial monotherapy in patients ≥ 10 years of age with partial onset or primary generalized tonic-clonic seizures (1.1)
-
Adjunctive therapy epilepsy: Adjunctive therapy for adults and pediatric patients (2 to 16 years of age) with partial onset seizures or primary generalized tonic-clonic seizures, and in patients ≥ 2 years of age with seizures associated with Lennox-Gastaut syndrome (LGS) (1.2)
|
|
DOSAGE AND ADMINISTRATION
|
|
See DOSAGE AND ADMINISTRATION, Epilepsy: Adjunctive Therapy Use for additional details (2.1)
|
|
Initial Dose |
Titration |
Recommended Dose |
|
Epilepsy monotherapy: adults and pediatric patients ≥ 10 years (2.1) |
50 m |
|
| |
